NVDA Q3 Earnings Alert: Why our AI share picker is still holding Nvidia sharesRead More

Oxford Vaccine Update Fails To Provide Boost In Uneven Monday Session

Published 21/07/2020, 06:06
EUR/USD
-
GBP/USD
-
UK100
-
DJI
-
DE40
-

There wasn’t much cohesion during Monday’s trading, a sign of a market struggling to find direction in a quagmire of covid-19 news.

Coming off the back of another weekend of record-breaking daily increases in new coronavirus cases domestically, a nightmare compounded by reports that Donald Trump is looking to stop billions in track-and-trace funding like a true madman, there was little to stop the Dow Jones falling after the bell.

Dropping 130 points the US index found itself slipping below 26550, a notable reversal from the 27200-pushing intraday highs seen last Wednesday.

The FTSE was on the Dow’s side this Monday, falling 0.6% to lurk around 6250. In contrast, the DAX turned things around to rise 75 points, re-crossing 13000 in the process.

The differing forms in the UK and Eurozone can be traced back to the respective performances of the pound and euro. Sterling shot up 0.6% against the dollar and 0.7% against the single currency, taking advantage of localised weaknesses in both of those regions.

The euro – which started the day on the front foot – gradually lost confidence as the day went on, its energy sapped by the lack of progress at the EU summit regarding a €750 billion covid-19 rescue-package.

It is worth noting that Monday’s uneven trading came in the face of a remarkably positive update from the Oxford vaccine trials, with the University stating the injection appears safe, and triggers an immune response in human patients.

The lack of market bounce following this news can be attributed to Robert Peston, who had already revealed last week that Oxford was preparing to release a promising statement. Monday’s release, then, was merely the confirmation of gains already made by Europe and the US.

"Disclaimer: Spreadex provides an execution only service and the comments above do not constitute (or should not be construed as constituting) investment advice or recommendations, or a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any person placing trades based on their interpretations of the above comments does so entirely at their own risk. Spreadex Ltd is a financial and sports spread betting and sports fixed odds betting firm, which specialises in the personal service and credit area. Founded in 1999, Spreadex is recognised as one of the longest established spread betting firms in the industry with a strong reputation for its high level of customer service and account management.

In relation to spread betting, Spreadex Ltd is authorised and regulated by the Financial Conduct Authority. Spread betting carries a high level of risk to your capital and can result in losses larger than your initial stake/deposit. It may not be suitable for everyone, so please ensure you fully understand the risks involved."

Original Post

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.